Zilong Zhou
-
- Cancer, Hypoxia, and Metabolism 4
-
- RNA modifications and cancer 6
- Receptor Mechanisms and Signaling 5
- Pharmacological Receptor Mechanisms and Effects 4
- Epigenetics and DNA Methylation 3
- RNA Research and Splicing 3
-
- Vascular Malformations and Hemangiomas 4
-
- Neuropeptides and Animal Physiology 3
In The Last Decade
Zilong Zhou
30 papers receiving 590 citations
Peers
Comparison fields: 5 of 85
- Cancer Research 102
- Molecular Biology 295
- Oncology 107
- Physiology 15
- Biomedical Engineering 119
Countries citing papers authored by Zilong Zhou
This map shows the geographic impact of Zilong Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zilong Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zilong Zhou more than expected).
Fields of papers citing papers by Zilong Zhou
This network shows the impact of papers produced by Zilong Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zilong Zhou. The network helps show where Zilong Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zilong Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 2 | |
| 6 | 2024 | 17 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 43 | |
| 9 | 2024 | 5 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 45 | |
| 12 | 2022 | 37 | |
| 13 | 2022 | 4 | |
| 14 | 2021 | 35 | |
| 15 | 2020 | 24 | |
| 16 | 2019 | 10 | |
| 17 | 2019 | 8 | |
| 18 | 2018 | 21 | |
| 19 | 2017 | 48 | |
| 20 | 2017 | 15 |
About Zilong Zhou
Zilong Zhou is a scholar working on Physiology, Cancer Research and Molecular Biology, having authored 35 papers that have together received 592 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Receptor Mechanisms and Signaling (5 papers), Pharmacological Receptor Mechanisms and Effects (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Vascular Malformations and Hemangiomas (4 papers), Neuropeptides and Animal Physiology (3 papers), Epigenetics and DNA Methylation (3 papers) and RNA Research and Splicing (3 papers). The work is most often cited by research in Cancer Research (102 citations), Molecular Biology (295 citations) and Oncology (107 citations). Zilong Zhou has collaborated with scholars based in China, Poland and Sweden. Frequent co-authors include Xianling Cong, Lele Cong, Jin‐Heng Li, Tingting Jiang, Hui Xu, Ping Gao, Huafeng Zhang, Linchong Sun, Wenhao Ma and Ren‐Jie Song. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.